(Alexandri, MN) Klobuchar’s staff will hold meetings with state and local health officials, first responders, health care providers, and treatment professionals to discuss the efforts to address the opioid and meth crisis in West Central Minnesota Thursday, May 23rd.

Members of the public are encouraged to join these discussions and share how people’s substance abuse disorders have impacted their lives

Representatives from U.S. Senator Amy Klobuchar’s office state and local health officials, first responders, health care providers, and treatment professionals to discuss the opioid and meth crisis and the impact of substance use disorders across the state. The conversation will also highlight Senator Klobuchar’s legislation to reduce opioid distribution, fund treatment, and improve prescribing. Most Americans know someone with a substance use disorder and one in seven people in the U.S. is expected to develop a substance use disorder at some point in their lives. Members of the public are encouraged to join these discussions and share how people’s substance abuse disorders have impacted their lives.

Thursday, May 23

10:30 a.m. – 11:30 a.m.

Alexandria City Hall, City Council Chambers

704 Broadway

Alexandria, MN 56308


1:30 p.m. – 2:30 p.m.

Fergus Falls City Hall, City Council Chambers

112 W Washington Ave

Fergus Falls, MN 56537


As a former Hennepin County Attorney, Klobuchar has long led local and national efforts to curb drug abuse and help people overcome addiction. In February 2018, Klobuchar and Senators Rob Portman (R-OH), Maggie Hassan (D-NH), Sheldon Whitehouse (D-RI), Shelley Moore Capito (R-WV), Dan Sullivan (R-AK), Bill Cassidy (R-LA), and Maria Cantwell (D-WA) introduced the bipartisan Comprehensive Addiction and Recovery Act (CARA) 2.0 Act. The bill would increase the funding authorization levels for the CARA programs enacted in 2016, and put in place additional policy reforms to help combat the opioid epidemic—including provisions from Klobuchar and Portman’s Prescription Drug Monitoring Act.


In October 2018, three of Klobuchar’s bipartisan bills to combat the opioid epidemic were signed into law as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. The Synthetic Abuse and Labeling of Toxic Substances (SALTS) Act, which Klobuchar introduced with Senator Lindsey Graham (R-SC), will make it easier to prosecute the sale and distribution of “analogue” drugs, which are synthetic substances that are substantially similar to illegal drugs. The Synthetics Trafficking & Overdose Prevention (STOP) Act, which Klobuchar introduced with Portman, will help stop dangerous synthetic drugs like fentanyl and carfentanil from being shipped through U.S. borders and into our communities. The Eliminating Kickbacks in Recovery Act, which Klobuchar introduced with Senator Marco Rubio (R-FL), will help crack down on health care facilities or providers that try to game the system to take advantage of vulnerable patients.


In February, Klobuchar and Portman reintroduced legislation to require that all states receiving certain federal funding to combat opioid abuse have prescription drug monitoring programs (PDMPs) using best practices, and also require states to make their PDMP data available to other states. PDMPs can identify and prevent unsafe prescribing practices and doctor shopping, helping to prevent addiction before it starts. Klobuchar also joined Senator Joe Manchin (D-WV) and other senators to reintroduce the Budgeting for Opioid Addiction Treatment (LifeBOAT) Act, which would establish a permanent funding stream to provide and expand access to treatment for addiction.